Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment. - Wikidata - awgldk - TriplyDB

Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.

Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.

http://www.wikidata.org/entity/Q37078982

about

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.

P2860

Q35024279-881F0CC9-449F-49A8-B11C-FA19D76A61EC Q38778145-1E28602C-C501-491C-AB80-138260026D42

P2860

Risperidone-associated prolactin elevation and markers of bone turnover during acute treatment.

http://www.wikidata.org/entity/Q37078982

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Risperidone-associated prolact ...... rnover during acute treatment.

@en

Risperidone-associated prolact ...... rnover during acute treatment.

@nl

type

label

Risperidone-associated prolact ...... rnover during acute treatment.

@en

Risperidone-associated prolact ...... rnover during acute treatment.

@nl

prefLabel

Risperidone-associated prolact ...... rnover during acute treatment.

@en

Risperidone-associated prolact ...... rnover during acute treatment.

@nl

P1433

Q37078982-25364271-211F-433C-97CC-DA2DE1D13730

P1476

Q37078982-4D08C9A3-993F-41BD-9FB0-C1A64FC0E563

P2093

Q37078982-0EE2F834-66A0-40EC-AFBA-40E84411BA85

Q37078982-14FAC2D5-0045-47A1-93B0-68A984E5EBB9

Q37078982-5B419AE8-7B1D-41B7-B65E-98EB2C5A63AF

Q37078982-5D1F17DD-70D1-4B14-969D-C53925A1CA33

Q37078982-F962A34D-7E41-4174-9CC0-E6A85452B1B5

P2860

Q37078982-0DF749AB-998B-42EC-9765-06D3E4714247

Q37078982-0F1857BA-9B03-4977-8313-D209C123997D

Q37078982-11F51AB5-340A-4D36-87C5-60692D662C3E

Q37078982-165D6946-02D2-43DB-90B2-6CC699A2AC7F

Q37078982-1C52F447-DB28-4568-9181-EF158FF4AD8E

Q37078982-1CBA9527-5535-484C-9B59-E27288249985

Q37078982-22B4AA53-CF5F-437E-864F-42059FCD7F49

Q37078982-2652AF55-EB23-4955-9907-C6BCA154FDDB

Q37078982-454233FE-EB46-4354-B966-67B20A5A4D62

Q37078982-5CDA61BC-8FAD-44A2-ACD9-3A8BE591013C

P304

Q37078982-F677259D-F5AE-44F8-8595-5885542D619F

P31

Q37078982-065908C1-C911-4996-89A0-2F501FB6A31B

P356

Q37078982-5975C43D-CDC9-404C-888D-10ACBE02E4CB

P433

Q37078982-5617FC2D-2575-45C4-B49F-71961AEAEBC1

P478

Q37078982-61825DC5-BAB1-4F17-AC4A-321146ED4B10

P577

Q37078982-70ADC957-B9C8-40E8-A7EA-1D92517B7B53

P5875

Q37078982-24B12D9C-75E2-453C-907C-89728397E7CD

P698

Q37078982-97F4B077-4F45-4B9D-8344-AB404A1D7907

P932

Q37078982-8A258665-A53E-4491-ABD8-F4D244424212

P356

2045125312442080

P1433

Therapeutic advances in psychopharmacology

P1476

Risperidone-associated prolact ...... rnover during acute treatment.

@en

P2093

James L Reilly

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Bishop

http://www.w3.org/2001/XMLSchema#string

John A Sweeney

http://www.w3.org/2001/XMLSchema#string

Leah H Rubin

http://www.w3.org/2001/XMLSchema#string

Mani N Pavuluri

http://www.w3.org/2001/XMLSchema#string

P2860

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

Prolactin and dopamine: what is the connection? A review article.

Calcium metabolism in schizophrenic patients on long-term neuroleptic therapy.

Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment

The effects of hyperprolactinemia on bone and fat.

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.

Role of prolactin in the regulation of sensitivity of the hypothalamic-pituitary system to steroid feedback.

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2045125312442080

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256190745

http://www.w3.org/2001/XMLSchema#string

P698

23983962

http://www.w3.org/2001/XMLSchema#string

P932

3736917

http://www.w3.org/2001/XMLSchema#string